Research Institute of McGill University Health Centre (RI-MUHC),
EM3.3232, 1001 Boul Décarie , the Glen site,
Montreal, QC H4A 3J1.
- Dr Routy strives to bring basic laboratory research into fruitful clinical trials.
- The main focus is on understanding HIV pathogenesis and restoring the immune system of individuals infected with HIV.
- Current studies include the use of interleukin-7 (a cytokine), or a dendritic cell-based therapeutic vaccine, or chloroquine (a commonly used anti-malarial drug) in addition to antiretrovirals to optimaly manage HIV infection.
- He is also the principle investigator of a national cohort of patients recently infected with HIV, which aims to understand the natural history of HIV infection, concentrating on its effect in the gut.
- Jean-Pierre Routy has dedicated the last two decades bringing science and treatment innovation to help combat the health challenges of HIV/ AIDS care.
- His fight in health and AIDS related malignancies has led him to obtain the McGill University Louis Lowenstein Chair in Hematology & Oncology.
- He is an attending physician in the Division of Hematology and Chronic Viral Illness Service at the MUHC Glen site and Professor in the department of Medicine and Experimental Medicine at McGill University, Montreal Canada.
- After completing his training in Medicine and Hematology-Oncology at University Aix-Marseille in 1986, he obtained a Postdoctoral Research Fellow Award from the Canadian HIV Trials Network (CTN) and became Assistant Professor in the Department of Medicine at the University of Montreal.
- In 1994, Dr. Routy joined McGill University and was promoted Associate Professor and co-director of the Flow Cytometry Laboratory at the Royal Victoria Hospital.
- In addition to his clinical research he was awarded Chair of the Royal Victoria Hospital Ethics Committee.
- As an FRSQ Clinician-Scientist, he was able to implement the Montreal Primary HIV-Infection cohort, which generated important findings in HIV pathogenesis and drug resistance.
- His achievements have led Dr. Routy to become the National Co-Director of the Immunotherapy and Vaccine Core at the Canadian Health Research Institutes for HIV Trials Network.
- Since 2011, he co-chairs the Eradication Clinical Working Group for the International AIDS Society.
- Dr. Routy was co-chair of the 2012 Canadian Association for HIV/AIDS Research Conference.
- Dr Routy has authored or co-authored over 210 peer-reviewed publications including articles in journals such as: New England Journal of Medicine, The Lancet, Nature Medicine, Blood and AIDS, he also authored a book entitled “What AIDS has changed” which he has won a literary award from the Ottawa Saint Paul University.